In the US, Nisoldipine (nisoldipine systemic) is a member of the drug class calcium channel blocking agents and is used to treat Angina Pectoris Prophylaxis, High Blood Pressure and Raynaud's Syndrome.
US matches:
- Nisoldipine Extended-Release Tablets
- Nisoldipine
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
C08CA07
CAS registry number (Chemical Abstracts Service)
0063675-72-9
Chemical Formula
C20-H24-N2-O6
Molecular Weight
388
Therapeutic Category
Calcium channel blocker
Chemical Name
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-, methyl 2-methylpropyl ester, (±)-
Foreign Names
- Nisoldipinum (Latin)
- Nisoldipin (German)
- Nisoldipine (French)
- Nisoldipino (Spanish)
Generic Names
- Nisoldipina (OS: DCIT)
- Nisoldipine (OS: USAN, DCF, JAN, BAN)
- Bay K 5552 (IS: Bayer)
Brand Names
- Baymycard
Bayer, Germany; Bayer, Hungary; Bayer, Romania; Bayer Yakuhin, Japan - Corasol
Sanitas, Chile - Nikameal
Towa Yakuhin, Japan - Ninobarucin
Choseido Pharmaceutical, Japan - Nisoldipine
Mylan, United States - Nisomynard
Yoshindo, Japan - Nivas
Tecnofarma, Chile - Nizoldin
Slaviamed, Serbia - Riohard
Taiyo Pharmaceutical, Japan - Sular
Bayer, Belgium; Bayer Animal Health, Luxembourg; Bayer Schering Pharma, Spain; Shionogi, United States - Syscor
AstraZeneca, Guyana; Bayer, Austria; Bayer, Belgium; Bayer, Finland; Bayer, Greece; Bayer, Italy; Bayer, Taiwan; Bayer Animal Health, Luxembourg; Bayer Schering Pharma, Spain; Eurim, Austria; Forest, United Kingdom
International Drug Name Search
Glossary
BAN | British Approved Name |
DCF | Dénomination Commune Française |
DCIT | Denominazione Comune Italiana |
IS | Inofficial Synonym |
JAN | Japanese Accepted Name |
OS | Official Synonym |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment